President Trump proposes a 200% tax on imported drugs, risking higher prices and shortages.

President Trump plans to impose a 200% tax on imported pharmaceuticals, risking higher drug prices and shortages in the U.S. The move could disrupt supply chains and raise costs at pharmacies and through insurance premiums, disproportionately affecting lower-income households and the elderly. Despite Trump's aim to lower drug costs, experts predict even a 25% tariff could increase U.S. drug prices by 10-14% as stockpiles dwindle. Some drugmakers are already expanding U.S. operations to avoid tariffs.